Position in DFTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,072,512
+$501,732 QoQ
Shares Held
22,800
-24.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 360 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DFTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names. DFTX ranks #5 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
23,500 | $1,916,895 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
163,220 | $1,428,991 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
23,166 | $1,398,299 | |
| 4 | ORMP |
Oramed Pharmaceuticals Inc.
|
233,018 | $1,120,816 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
This page
|
22,800 | $1,072,512 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
11,790 | $1,025,140 | |
| 7 | MRNA |
Moderna, Inc.
|
9,474 | $663,464 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,044 | $518,586 |
All Filings in DFTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,072,512 | 22,800 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $570,780 | 30,200 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||